Show simple item record

dc.contributor.authorShamash, Jen_US
dc.contributor.authorPowles, Ten_US
dc.contributor.authorAnsell, Wen_US
dc.contributor.authorStebbing, Jen_US
dc.contributor.authorMutsvangwa, Ken_US
dc.contributor.authorWilson, Pen_US
dc.contributor.authorAsterling, Sen_US
dc.contributor.authorLiu, Sen_US
dc.contributor.authorWyatt, Pen_US
dc.contributor.authorJoel, SPen_US
dc.contributor.authorOliver, RTDen_US
dc.date.accessioned2016-04-25T12:25:57Z
dc.date.issued2007-07-31en_US
dc.identifier.issn0007-0920en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/12053
dc.description.sponsorshipThe funding for the pharmacokinetic studies and data management was provided through a grant from The Orchid Cancer Appeal.en_US
dc.format.extent308 - 314en_US
dc.relation.ispartofBRIT J CANCERen_US
dc.rightsthis work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subjectGAMECen_US
dc.subjectmethotrexateen_US
dc.subjecthigh doseen_US
dc.subjectgerm cellen_US
dc.subjectCANCER-STUDY-GROUPen_US
dc.subjectSALVAGE CHEMOTHERAPYen_US
dc.subjectPOMB/ACE CHEMOTHERAPYen_US
dc.subjectRANDOMIZED TRIALen_US
dc.subjectDOSE INTENSITYen_US
dc.subjectIFOSFAMIDEen_US
dc.subjectCISPLATINen_US
dc.subjectETOPOSIDEen_US
dc.subjectPACLITAXELen_US
dc.subjectPHARMACOKINETICSen_US
dc.titleGAMEC - a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumoursen_US
dc.typeArticle
dc.identifier.doi10.1038/sj.bjc.6603865en_US
pubs.issue3en_US
pubs.notesNot knownen_US
pubs.volume97en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record